FDA Inspection 769906 — VivaCeuticals, Inc. dba Regeneca Worldwide
The FDA completed an inspection of VivaCeuticals, Inc. dba Regeneca Worldwide on February 23, 2012 in Irvine, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 23, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Unapproved and Misbranded Drugs
- Location
- Irvine, CA (United States)